{
 "generic_name": "Travoprost Ophthalmic Solution",
 "slug": "travoprost-ophthalmic-solution",
 "brand_names": [
  "Travoprost Ophthalmic Solution, 0.004%"
 ],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "07/07/2026",
 "first_posted": "07/07/2026",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "package_ndc": "0378-9651-32",
   "presentation": "Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug"
  },
  {
   "company": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "package_ndc": "0378-9651-50",
   "presentation": "Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug"
  }
 ],
 "changes": []
}